HEMOSTASIS COAGULATION ROUTINE REAGENTS ANTICOAGULANT MONITORING DOAC DOAC NEUTRALIZATION
HEMOSTASIS COAGULATION ROUTINE REAGENTS AUXILIARY REAGENTS NEUTRALIZERS
DOAC-Stop™
Suppresses all types of NOAC, including dabigatran, apixaban, rivaroxaban and edoxaban, with minimal effect on currently known coagulation variables.
Advantages
DOAC-Stop is designed for use on citrated plasma. The tablets are dissolved in the citrated plasma, then after centrifugation, the supernatant containing no more DOAC is ready to be used.
Informations
The therapeutic uses of NOAC are increasing. NOACs are known to interfere with almost all coagulation tests to varying degrees and sometimes patients who need to be tested for underlying coagulation defects may also be on NOAC.
DOAC-Stop ™ is the first general agent available to solve diagnostic problems associated with NOACs.
After treatment with DOAC-Stop ™, plasma samples can be analyzed for underlying clotting defects such as factor deficiencies, heparin, lupus anticoagulant, or other interfering antibodies.
Documentation
Download the product sheetPrice list, safety data sheets and notices are accessible to our registered customers.
Neutralizing
References
| 20-HX9904-50 | Tablets | 1 x 50 | 50 tests |
| 20-HX9904-100 | Tablets | 1 x 100 | 100 tests |
